China granted regulatory clearance to Cytori Therapeutics Inc.'s (Nasdaq:
CYTX) exclusive licensee Lorem Vascular to market and sell the Cytori
Celution System. The stock price climbed 16 cents to close at $1.32.
Cytori Therapeutics receives approval
April 06, 2015 at 17:41 PM EDT